Edition:
United States

Health News

Photo

Trump's drug czar nominee withdraws from consideration 2:57pm EDT

WASHINGTON The U.S. lawmaker who was President Donald Trump's pick for drug czar withdrew on Tuesday after it became public he spearheaded a bill that hurt the government's ability to crack down on opioid makers flooding the market with the addictive painkillers. | Video

More Headlines

Photo

UnitedHealth sees growth in 2018, opportunities in Trump plans

UnitedHealth Group Inc, the largest U.S. health insurer, said earnings will grow 13 to 16 percent in 2018 as medical costs remain low, and that it expects to benefit from new insurance products backed by U.S. President Donald Trump.

2:22pm EDT

Transenterix won't compete head-on with Intuitive Surgical: CEO

Transenterix Inc's chief executive played down on Tuesday the threat posed by his company's surgical robotic system to market leader Intuitive Surgical Inc, saying he did not expect the two to compete head on.

Tech 12:53pm EDT

Fatty liver disease fastest-growing reason for transplants in young U.S. adults

(Reuters Health) - Nonalcoholic fatty liver disease and its more aggressive form, nonalcoholic steatohepatitis, have become the fastest-growing reasons for liver transplants in young Americans, according to a recent study.

12:21pm EDT

Drugmakers Amneal, Impax to combine in generics push

Amneal Pharmaceuticals LLC is buying peer Impax Laboratories Inc in an all-stock deal as it looks to add heft to its generics business and gain an edge in a tough drug pricing environment.

Deals, Drug Pricing 9:54am EDT

Health Watch Graphics